Bioscience company receives $15 million in funding

The funding will support the international commercial expansion of the FebriDx rapid point-of-care test.

By Business Observer Staff
| 6:34 p.m. February 5, 2020
| 0 Free Articles Remaining!

Courtesy. Dr.Â Robert Sambursky,Â president and CEO of Lumos Diagnostics. Lumos DiagnosticsÂ announced the closing of $15 million in Series A funding fromÂ Planet Innovation.

Manatee-Sarasota

A bioscience company born in Lakewood Ranch 15 years ago that, more recently, merged with a California firm, has hit a major milestone: it received $15 million in funding.

The funds are for Lumos Diagnostics, a Carlsbad, Calif. company that merged with Lakewood Ranch-based RPS Diagnostics in May. Founded in 2004, RPS, now under the Lumos name, is a commercial developer, manufacturer and marketer of diagnostic tests, with a focus on commercializing products for infectious and inflammatory diseases. Lumos develops digital readers for the same technology; the company maintains an operating headquarters in Lakewood Ranch.